ConductScience.org, home

Library / Trials

AMPLIFI: Adaptive Modulation of Plasticity Through Lactate and Fitness Interventions

NCT06950060, Not applicable, Active not recruiting, University of Alabama at Birmingham

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleAMPLIFI: Adaptive Modulation of Plasticity Through Lactate and Fitness InterventionsClinicalTrials.gov
NCT numberNCT06950060ClinicalTrials.gov
StatusActive not recruitingClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment48 participants, estimatedClinicalTrials.gov
Lead sponsorUniversity of Alabama at BirminghamClinicalTrials.gov
ConditionsStroke, Chronic, Aging, Cognitive Decline, Motor Dysfunction, NeuroplasticityClinicalTrials.gov
InterventionsHigh intensity cycling, Low-intensity cycling, Health education session, Moderate Intensity Aerobic ExerciseClinicalTrials.gov
First posted2025-04-29ClinicalTrials.gov
Last updated2026-07-17ClinicalTrials.gov

Registered outcomes 5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryMotor Learning Performance (12-Digit Serial Reaction Time Task)Baseline, Day 2, Day 3, Day 4, and Day 5
Motor learning is assessed using the 12-digit Serial Reaction Time Task (SRTT), a computer-based measure of implicit motor sequence learning. Participants respond to visual cues by pressing buttons in a fixed or random sequence. Learning is quantified by changes in reaction time and accuracy across structured and unstructured trials. A learning index is derived by comparing performance between patterned (learning) and random sequences.
ClinicalTrials.gov
SecondaryChange in Long-Interval Intracortical Inhibition (LICI)Baseline, Day 5LICI is measured using a 100 ms interstimulus interval to assess GABA\<sub\>B\</sub\>-mediated inhibition. Recorded before and after each intervention session.ClinicalTrials.gov
SecondaryChange in Intracortical Facilitation (ICF)Baseline, Day 5ICF is assessed using paired-pulse TMS with a 10-15 ms interstimulus interval to evaluate cortical excitability.ClinicalTrials.gov
SecondaryChange in Blood Lactate ConcentrationDay 2, Day 3, Day 4Measured via fingerstick blood samples pre-, mid-, and post-exercise.ClinicalTrials.gov
SecondaryChange in Executive Function (D-KEFS Verbal Fluency and Stroop Tests)Day 1 and Day 5Executive function neuropsychological tests.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 4

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Motor Sequence TaskPrimary outcomeConductCognition
Serial Reaction TimePrimary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition
Verbal FluencySecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)